A Study Called Champion-HMB to Learn More About Females With Heavy Menstrual Bleeding and Available Treatments to Enable Earlier Diagnosis and to Predict Courses of Treatment
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Bayer
Related studies linked through entity extraction aliases.
Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)
- Status
- COMPLETED
- Phase
- N/A
A Study Called AWARENESS Using Data From Men in Alberta to Observe Treatment Patterns for Metastatic Castration-sensitive Prostate Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood
- Status
- COMPLETED
- Phase
- PHASE3
Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE2
Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastases
- Status
- RECRUITING
- Phase
- PHASE3
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)
- Status
- COMPLETED
- Phase
- N/A
First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants Whose Immune System Works Normally
- Status
- COMPLETED
- Phase
- PHASE3
A Study in Healthy Adult Male Participants to Learn the Way Vericiguat is Absorbed With and Without Food When Taken as a Single Dose in Liquid Form Suitable for Children Compared to a 10 Milligram (mg) Tablet That Releases the Active Substance Immediately
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Gather Information About the Progress and Outcomes of Pregnancy in Women Using Various Vitamin Support Plans Before and During Pregnancy
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Pharmacokinetics (How it Moves Into, Through and Out From the Body) of a New Gadolinium-based Contrast Agent (GBCA) After Injection and How Safe it is in Participants With Normal and Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Surgical Window of Opportunity Study of Orally Administered BAY 2402234 in Recurrent Glioma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1